Correlation Between Avita Medical and Neuropace

Can any of the company-specific risk be diversified away by investing in both Avita Medical and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avita Medical and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avita Medical and Neuropace, you can compare the effects of market volatilities on Avita Medical and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avita Medical with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avita Medical and Neuropace.

Diversification Opportunities for Avita Medical and Neuropace

-0.47

Correlation Coefficient

Avita Medical  Neuropace

Very good diversification

The 3 months correlation between Avita and Neuropace is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Avita Medical and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Avita Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avita Medical are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Avita Medical i.e., Avita Medical and Neuropace go up and down completely randomly.

Pair Corralation between Avita Medical and Neuropace

Given the investment horizon of 90 days Avita Medical is expected to under-perform the Neuropace. In addition to that, Avita Medical is 1.65 times more volatile than Neuropace. It trades about -0.07 of its total potential returns per unit of risk. Neuropace is currently generating about 0.02 per unit of volatility. If you would invest  1,193  in Neuropace on December 3, 2024 and sell it today you would earn a total of  0.00  from holding Neuropace or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Avita Medical  vs.  Neuropace

Avita Medical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Avita Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Neuropace

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Neuropace is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Avita Medical and Neuropace

The main advantage of trading using opposite Avita Medical and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avita Medical position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind Avita Medical and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.